Methadone Hydrochloride Market
- 2026 年市場規模
- USD 136.8 Mn
- 2033 年預估規模
- USD 186.3 Mn
- 年複合成長率 CAGR
- 4.5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Methadone Hydrochloride Market, By Formulation (Tablet, Solution, Others), By Application (Opiate Withdrawal, Chronic Pain, Others), By Route of Administration (Oral, Intravenous), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)
報告摘要
Methadone, a synthetic narcotic analgesic is part of a category called opioids. This opioid has pharmacologic actions qualitatively similar to morphine. Methadone is generally used as a pain reliever and as a part of drug addiction detoxification and maintenance therapy. Pain can be of various types such as due to surgery, strain, and others. A person experiencing severe and chronic pain is given small doses of methadone, which encounters the pain by changing the way the brain and nervous system respond to pain. Opiate dependence is a major public health problem.
Market Dynamics
Key players are focusing on mergers and acquisitions to strengthen their position in the global methadone hydrochloride market. For instance, in May 2016, Hikma Pharmaceuticals PLC acquired Roxane Laboratories, Inc., a pharmaceutical company. Through this acquisition, the company expanded its product portfolio of opiate agonist by acquiring methadone hydrochloride from Roxane Laboratories, Inc
Key features of the study
• This report studies the current scenario as well as the future market potential of methadone hydrochloride across the globe. The market for methadone hydrochloride has been segmented on the basis of formulation, application, route of administration, distribution channel, and region.
• This report provides in-depth analysis of the global methadone hydrochloride market, and provides market size (US$ Mn) and compound annual growth rate (CAGR) (%) for the forecast period (2026-2033)
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market. It provides valuable insights about market drivers, restraints, opportunities, regional outlook, and competitive strategies adopted by the leading players.
• It profiles leading players in the global methadone hydrochloride market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, key developments, and future plans
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions with respect to their future market expansion and marketing tactics
• Key companies covered as a part of this study are Eli Lilly and Company, Sanofi S.A, Hikma Pharmaceuticals PLC, Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Tianjin Central Pharmaceutical Co., Ltd, Temad Co, Embio LTD, Harman Finochem Ltd, and Rusan Pharma Ltd.
• The global methadone hydrochloride market report caters to various stakeholders in this industry, including investors, product developers and manufacturers, distributors, healthcare organizations, research institutes, new entrants, and financial analysts
• Stakeholders would greatly benefit in decision-making through various strategy matrices used in analyzing the global methadone hydrochloride market
Market Segmentation
• By Formulation Insights (Revenue, USD Mn, 2021 - 2033)
o Tablet
o Solution
o Others
• By Application Insights (Revenue, USD Mn, 2021 - 2033)
o Opiate Withdrawal
o Chronic Pain
o Others
• By Route of Administration Insights (Revenue, USD Mn, 2021 - 2033)
o Oral
o Intravenous
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospital Pharmacies
o Retail Pharmacies
o Online Pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East & Africa
GCC Countries
Israel
Rest of Middle East & Africa
• Key Players
o Eli Lilly and Company
o Sanofi S.A
o Hikma Pharmaceuticals PLC
o Mallinckrodt Pharmaceuticals
o Siegfried Holding AG
o Johnson Matthey
o Tianjin Central Pharmaceutical Co., Ltd
o Temad Co
o Embio LTD
o Harman Finochem Ltd
o Rusan Pharma Ltd
目錄 Table of Contents
Table of Content
1. Research Objectives and Assumptions
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snapshot, By Formulation
Market Snapshot, By Application
Market Snapshot, By Route of Administration
Market Snapshot, By Distribution Channel
Market Snapshot, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Drivers and Restraints
o Opportunities
o Impact Analysis
o Recent Product launches and Approvals
o Pipeline Analysis
o Brand Analysis
o Regulatory Scenario
o PEST Analysis
o Epidemiology
o Reimbursement Scenario
o Acquisition
o Market Trend
4. Global Methadone Hydrochloride Market, By Formulation, 2021-2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Tablet
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Solution
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
5. Global Methadone Hydrochloride Market, By Application, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Opiate Withdrawal
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Chronic Pain
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Others
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
6. Global Methadone Hydrochloride Market, By Route of Administration, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Intravenous
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
7. Global Methadone Hydrochloride Market, By Distribution Channel, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hospital Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Retail Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Online Pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
8. Global Methadone Hydrochloride Market, By Region, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, By Country, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Countries, 2022–2033
o North America
Introduction
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Application 2021–2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o U.S.
o Canada
o Latin America
Introduction
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Application 2021–2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Europe
Introduction
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Application 2021–2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o Germany
o U.K.
o France
o Italy
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Introduction
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Application 2021–2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o China
o India
o Japan
o Australia
o South Korea
o ASEAN
o Rest of Asia Pacific
o Middle East
Introduction
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Application 2021–2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
o Africa
Introduction
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Application 2021–2033 (USD Mn)
Market Size and Forecast, By Route of Administration, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country/Region, 2021–2033 (USD Mn)
o South Africa
o Central Africa
o North Africa
9. Competitive Landscape
o Company Profiles
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Sanofi S.A
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Hikma Pharmaceuticals PLC
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Mallinckrodt Pharmaceuticals
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Siegfried Holding AG
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Johnson Matthey
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Tianjin Central Pharmaceutical Co., Ltd
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Temad Co
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Embio LTD
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Harman Finochem Ltd
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
Rusan Pharma Ltd
o Company Overview
o Product Portfolio
o Financial Overview
o Key Highlights
o Market Strategies
o Analyst View
10. Section
o References
o Research Methodology
o About Us
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們